BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26047578)

  • 1. Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.
    Phillips JD; Knab LM; Blatner NR; Haghi L; DeCamp MM; Meyerson SL; Heiferman MJ; Heiferman JR; Gounari F; Bentrem DJ; Khazaie K
    Cancer Immunol Immunother; 2015 Sep; 64(9):1185-91. PubMed ID: 26047578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of expanded Foxp3⁺ Helios⁻ regulatory T cells in patients with non-small cell lung cancer.
    Muto S; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Okabe N; Matsumura Y; Hasegawa T; Osugi J; Hoshino M; Higuchi M; Suzuki H; Gotoh M
    Int J Oncol; 2015 Dec; 47(6):2082-90. PubMed ID: 26460798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalance between subpopulations of regulatory T cells in COPD.
    Hou J; Sun Y; Hao Y; Zhuo J; Liu X; Bai P; Han J; Zheng X; Zeng H
    Thorax; 2013 Dec; 68(12):1131-9. PubMed ID: 23749814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension.
    Sada Y; Dohi Y; Uga S; Higashi A; Kinoshita H; Kihara Y
    Heart Vessels; 2016 Aug; 31(8):1319-26. PubMed ID: 26319442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.
    Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Iwata T; Uramoto H; So T; Tanaka F
    Lung Cancer; 2013 Sep; 81(3):475-479. PubMed ID: 23891508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an antihuman CCR4 mAb (KM2760).
    Kurose K; Ohue Y; Sato E; Yamauchi A; Eikawa S; Isobe M; Nishio Y; Uenaka A; Oka M; Nakayama E
    J Thorac Oncol; 2015 Jan; 10(1):74-83. PubMed ID: 25325779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
    Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D
    Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
    Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
    J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.
    Yin M; Zhang J; Wang Y; Wang S; Böckler D; Duan Z; Xin S
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1825-31. PubMed ID: 20448211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
    Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
    Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory CD4+ T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients?
    Janssen KM; Westra J; Chalan P; Boots AM; de Smit MJ; van Winkelhoff AJ; Vissink A; Brouwer E
    PLoS One; 2016; 11(9):e0162101. PubMed ID: 27585422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionally distinct subsets of CD4⁺ regulatory T cells in patients with laryngeal squamous cell carcinoma are indicative of immune deregulation and disease progression.
    Sun W; Li WJ; Fu QL; Wu CY; Lin JZ; Zhu XL; Hou WJ; Wei Y; Wen YH; Wang YJ; Wen WP
    Oncol Rep; 2015 Jan; 33(1):354-62. PubMed ID: 25333227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.